SCHEMBL4296140

SCHEMBL4296140

CC(C)(C)OC(=O)N1CCC(C(=O)O[Si](C)(C)C(C)(C)C)C1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.52
RECQL P46063 1/20 0.50
MEN1 O00255 1/20 0.45
ALDH1A1 P00352 1/20 0.45
MAPT P10636 1/20 0.45
KMT2A Q03164 1/20 0.45
EPHX1 P07099 1/20 0.44
PTPN2 P17706 1/20 0.43
PTPN1 P18031 1/20 0.43
PTPN6 P29350 1/20 0.43
USP30 Q70CQ3 3/20 0.42
USP2 O75604 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
STS P08842 4/20 0.41
HSD17B10 Q99714 1/20 0.40
GPR119 Q8TDV5 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
ABL1 P00519 1/20 0.40
RIN1 Q13671 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30885566 0.84 HPGD (0.62) HPGDRECQLMEN1ALDH1A1MAPT
SCHEMBL1119307 0.81 HPGD (0.59) HPGDRECQLMEN1ALDH1A1MAPT
SCHEMBL1968331 0.81 HPGD (0.59) HPGDRECQLMEN1ALDH1A1MAPT
SCHEMBL1973022 0.81 HPGD (0.59) HPGDRECQLMEN1ALDH1A1MAPT
SCHEMBL15367663 0.80 HPGD (0.57) HPGDRECQLMEN1ALDH1A1MAPT
SCHEMBL28263415 0.79 HPGD (0.64) HPGDRECQLMEN1ALDH1A1MAPT
SCHEMBL3759130 0.78 HPGD (0.52) HPGDRECQLMEN1ALDH1A1MAPT
SCHEMBL42958 0.77 HPGD (0.62) HPGDRECQLMEN1ALDH1A1MAPT
SCHEMBL10233234 0.77 HPGD (0.62) HPGDRECQLMEN1ALDH1A1MAPT
SCHEMBL42957 0.77 HPGD (0.62) HPGDRECQLMEN1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090270379-A1 QUINOLONE DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS JANSSEN PHARMACEUTICA N.V. (BE) 2009-10-29 US disclosed
WO-2009131973-A1 QUINOLONE DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS JANSSEN PHARMACEUTICA NV (BE) 2009-10-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270379-A1 QUINOLONE DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS NQO2, QARS1, NQO1 HPGD 203/4885RECQL 36/4885MEN1 3858/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.